GB2105990B
(en)
*
|
1981-08-27 |
1985-06-19 |
Nitto Electric Ind Co |
Adhesive skin patches
|
US4460370A
(en)
*
|
1981-10-29 |
1984-07-17 |
Almedco, Inc. |
Trans-dermal medication application cell
|
DE3204582A1
(de)
*
|
1982-02-10 |
1983-08-25 |
Hassia Verpackung Gmbh, 6479 Ranstadt |
Verfahren zur kontinuierlichen herstellung von pflasterpackungen fuer die transdermale verabreichung von medikamenten
|
DE3347277A1
(de)
*
|
1983-12-28 |
1985-07-11 |
Bayer Ag, 5090 Leverkusen |
Wirkstoffabgabesysteme
|
US4573996A
(en)
*
|
1984-01-03 |
1986-03-04 |
Jonergin, Inc. |
Device for the administration of an active agent to the skin or mucosa
|
EP0156080B2
(fr)
*
|
1984-03-05 |
1993-10-20 |
Nitto Denko Corporation |
Préparation pharmaceutique adhésive du type à absorption percutanée
|
US4704282A
(en)
*
|
1984-06-29 |
1987-11-03 |
Alza Corporation |
Transdermal therapeutic system having improved delivery characteristics
|
US4725439A
(en)
*
|
1984-06-29 |
1988-02-16 |
Alza Corporation |
Transdermal drug delivery device
|
DE3424837C1
(de)
*
|
1984-07-03 |
1986-01-16 |
Hassia-Verpackung Karl Klein Gmbh, 1000 Berlin |
Depot-Pflaster
|
US4588580B2
(en)
*
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
US4649075A
(en)
*
|
1984-08-09 |
1987-03-10 |
Leonora Jost |
Transdermal and transmucosal vortexed foam devices and the method of making
|
ES8608895A1
(es)
*
|
1984-08-17 |
1986-07-16 |
Allpack Ind Lohnverpackung |
Parche adhesivo farmaceutico y procedimiento para su fabri- cacion
|
US4927687A
(en)
*
|
1984-10-01 |
1990-05-22 |
Biotek, Inc. |
Sustained release transdermal drug delivery composition
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
KR930009787B1
(ko)
*
|
1984-10-11 |
1993-10-11 |
케이 파마큐티칼스 |
약제의 경피성 도출계 및 그의 제조방법
|
US4883669A
(en)
*
|
1985-02-25 |
1989-11-28 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
|
US4645502A
(en)
*
|
1985-05-03 |
1987-02-24 |
Alza Corporation |
Transdermal delivery of highly ionized fat insoluble drugs
|
US4904475A
(en)
*
|
1985-05-03 |
1990-02-27 |
Alza Corporation |
Transdermal delivery of drugs from an aqueous reservoir
|
GB8512358D0
(en)
*
|
1985-05-16 |
1985-06-19 |
Euro Celtique Sa |
Transdermal delivery system
|
US4690683A
(en)
*
|
1985-07-02 |
1987-09-01 |
Rutgers, The State University Of New Jersey |
Transdermal varapamil delivery device
|
US4698062A
(en)
*
|
1985-10-30 |
1987-10-06 |
Alza Corporation |
Medical device for pulsatile transdermal delivery of biologically active agents
|
WO1987003477A1
(fr)
*
|
1985-12-12 |
1987-06-18 |
Flexcon Company, Inc. |
Procedes et adhesifs transdermiques
|
US4710191A
(en)
*
|
1985-12-16 |
1987-12-01 |
Jonergin, Inc. |
Therapeutic device for the administration of medicaments
|
US4666441A
(en)
*
|
1985-12-17 |
1987-05-19 |
Ciba-Geigy Corporation |
Multicompartmentalized transdermal patches
|
ES2029850T3
(es)
*
|
1986-02-14 |
1992-10-01 |
Ciba-Geigy Ag |
Sistemas terapeuticos dermicos y transdermicos con capa adhesiva aplicada en forma de muestra.
|
US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
ATE71287T1
(de)
*
|
1986-06-13 |
1992-01-15 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
US4755180A
(en)
*
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
US6126963A
(en)
*
|
1986-08-28 |
2000-10-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US6110488A
(en)
*
|
1986-08-28 |
2000-08-29 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US6139868A
(en)
*
|
1986-08-28 |
2000-10-31 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US5820876A
(en)
|
1986-08-28 |
1998-10-13 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system
|
DE3629304A1
(de)
*
|
1986-08-28 |
1988-03-24 |
Lohmann Gmbh & Co Kg |
Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
|
US6117448A
(en)
*
|
1986-08-28 |
2000-09-12 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
USRE37934E1
(en)
|
1986-08-28 |
2002-12-10 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system
|
US4938759A
(en)
*
|
1986-09-02 |
1990-07-03 |
Alza Corporation |
Transdermal delivery device having a rate controlling adhesive
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US5422118A
(en)
*
|
1986-11-07 |
1995-06-06 |
Pure Pac, Inc. |
Transdermal administration of amines with minimal irritation and high transdermal flux rate
|
US4863970A
(en)
*
|
1986-11-14 |
1989-09-05 |
Theratech, Inc. |
Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
|
AU601528B2
(en)
*
|
1986-12-22 |
1990-09-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
|
US4906463A
(en)
*
|
1986-12-22 |
1990-03-06 |
Cygnus Research Corporation |
Transdermal drug-delivery composition
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
US5006342A
(en)
*
|
1986-12-22 |
1991-04-09 |
Cygnus Corporation |
Resilient transdermal drug delivery device
|
US5322695A
(en)
*
|
1987-01-09 |
1994-06-21 |
Hercon Laboratories Corporation |
Moisture-vapor-permeable dressing
|
US4940586A
(en)
*
|
1987-02-26 |
1990-07-10 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4816258A
(en)
*
|
1987-02-26 |
1989-03-28 |
Alza Corporation |
Transdermal contraceptive formulations
|
US4865848A
(en)
*
|
1987-02-26 |
1989-09-12 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4746515A
(en)
*
|
1987-02-26 |
1988-05-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolaurate
|
US4788062A
(en)
*
|
1987-02-26 |
1988-11-29 |
Alza Corporation |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
|
US5071656A
(en)
*
|
1987-03-05 |
1991-12-10 |
Alza Corporation |
Delayed onset transdermal delivery device
|
US5077054A
(en)
*
|
1987-03-09 |
1991-12-31 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5118509A
(en)
*
|
1987-03-09 |
1992-06-02 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
US5171576A
(en)
*
|
1987-03-09 |
1992-12-15 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5049387A
(en)
*
|
1987-03-09 |
1991-09-17 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
US5000956A
(en)
*
|
1987-03-09 |
1991-03-19 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
CH674618A5
(fr)
*
|
1987-04-02 |
1990-06-29 |
Ciba Geigy Ag |
|
US5045553A
(en)
*
|
1987-06-24 |
1991-09-03 |
Fujisawa Pharmaceutical Company, Ltd. |
Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
|
US4804541A
(en)
*
|
1987-08-11 |
1989-02-14 |
Moleculon, Inc. |
Transdermal administration using benzyl alcohol
|
US4764379A
(en)
*
|
1987-08-24 |
1988-08-16 |
Alza Corporation |
Transdermal drug delivery device with dual permeation enhancers
|
US4820720A
(en)
*
|
1987-08-24 |
1989-04-11 |
Alza Corporation |
Transdermal drug composition with dual permeation enhancers
|
US4917895A
(en)
*
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
US4781924A
(en)
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
US4837027A
(en)
*
|
1987-11-09 |
1989-06-06 |
Alza Corporation |
Transdermal drug delivery device
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
FR2623718B1
(fr)
*
|
1987-11-27 |
1994-04-15 |
Fabre Medicament Pierre |
Dispositif therapeutique transdermique et son procede de preparation
|
US5068226A
(en)
*
|
1987-12-07 |
1991-11-26 |
Cyclex, Inc. |
Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
|
US4979946A
(en)
*
|
1987-12-14 |
1990-12-25 |
The Kendall Company |
Environmental absorbent dressing
|
US5925372A
(en)
*
|
1987-12-16 |
1999-07-20 |
Novartis Corporation |
Mixed solvent mutually enhanced transdermal therapeutic system
|
US5064654A
(en)
*
|
1989-01-11 |
1991-11-12 |
Ciba-Geigy Corporation |
Mixed solvent mutually enhanced transdermal therapeutic system
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US5223261A
(en)
*
|
1988-02-26 |
1993-06-29 |
Riker Laboratories, Inc. |
Transdermal estradiol delivery system
|
US4885154A
(en)
*
|
1988-03-01 |
1989-12-05 |
Alza Corporation |
Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
|
US5300291A
(en)
*
|
1988-03-04 |
1994-04-05 |
Noven Pharmaceuticals, Inc. |
Method and device for the release of drugs to the skin
|
US5719197A
(en)
*
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
US5378730A
(en)
*
|
1988-06-09 |
1995-01-03 |
Alza Corporation |
Permeation enhancer comprising ethanol and monoglycerides
|
US5641504A
(en)
*
|
1988-06-09 |
1997-06-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolinoleate
|
US5004610A
(en)
*
|
1988-06-14 |
1991-04-02 |
Alza Corporation |
Subsaturated nicotine transdermal therapeutic system
|
PT90820B
(pt)
*
|
1988-06-14 |
1995-05-31 |
Alza Corp |
Dispositivo de libertacao transdermica sub-saturado
|
US5181914A
(en)
*
|
1988-08-22 |
1993-01-26 |
Zook Gerald P |
Medicating device for nails and adjacent tissue
|
US5200190A
(en)
*
|
1988-10-11 |
1993-04-06 |
Sekisui Kagaku Kogyo Kabushiki Kaisha |
Percutaneous pharmaceutical preparation
|
US5026556A
(en)
*
|
1988-11-10 |
1991-06-25 |
Norwich Eaton Pharmaceuticals, Inc. |
Compositions for the transdermal delivery of pharmaceutical actives
|
IL92496A0
(en)
*
|
1988-12-01 |
1990-08-31 |
Schering Corp |
Compositions for transdermal delivery of estradiol
|
US5332577A
(en)
*
|
1988-12-27 |
1994-07-26 |
Dermamed |
Transdermal administration to humans and animals
|
US5241925A
(en)
*
|
1988-12-27 |
1993-09-07 |
Dermamed |
Apparatus and techniques for administering veterinary medicaments
|
US5223262A
(en)
*
|
1989-02-23 |
1993-06-29 |
University Of Utah |
Transdermal delivery system utilizing one way membranes
|
US4973468A
(en)
*
|
1989-03-22 |
1990-11-27 |
Cygnus Research Corporation |
Skin permeation enhancer compositions
|
US5053227A
(en)
*
|
1989-03-22 |
1991-10-01 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US5059426A
(en)
*
|
1989-03-22 |
1991-10-22 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US5788983A
(en)
*
|
1989-04-03 |
1998-08-04 |
Rutgers, The State University Of New Jersey |
Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
|
US5139023A
(en)
*
|
1989-06-02 |
1992-08-18 |
Theratech Inc. |
Apparatus and method for noninvasive blood glucose monitoring
|
KR920700014A
(ko)
*
|
1989-06-02 |
1992-02-19 |
테오도르 에이취. 스탠리 |
비침입적인 혈중 글루코오스의 검사 장치 및 방법
|
EP0409383B1
(fr)
*
|
1989-07-21 |
1994-04-06 |
Izhak Blank |
Compositions à base d'estradiol et procédés d'application topique
|
US4956171A
(en)
*
|
1989-07-21 |
1990-09-11 |
Paco Pharmaceutical Services, Inc. |
Transdermal drug delivery using a dual permeation enhancer and method of performing the same
|
US5232703A
(en)
*
|
1989-07-21 |
1993-08-03 |
Izhak Blank |
Estradiol compositions and methods for topical application
|
US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
US5324521A
(en)
*
|
1989-12-18 |
1994-06-28 |
Dermamed |
Systems for transdermal administration of medicaments
|
DE69029909T2
(de)
|
1990-03-28 |
1997-09-11 |
Noven Pharma |
Verfahren und vorrichtung zur freisetzung von arzneimittel an die haut
|
US5508038A
(en)
*
|
1990-04-16 |
1996-04-16 |
Alza Corporation |
Polyisobutylene adhesives for transdermal devices
|
EP1093816A3
(fr)
*
|
1990-06-01 |
2003-10-22 |
The Population Council, Inc. |
Utilisation de la ST1435 dans la thérapie hormonale par voie transdermique
|
US5071704A
(en)
*
|
1990-06-13 |
1991-12-10 |
Fischel Ghodsian Fariba |
Device for controlled release of vapors and scents
|
US5455043A
(en)
*
|
1990-06-13 |
1995-10-03 |
Fischel-Ghodsian; Fariba |
Device for controlled release of vaporous medications through nasal route
|
US5160741A
(en)
*
|
1990-07-06 |
1992-11-03 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5130139A
(en)
*
|
1990-07-06 |
1992-07-14 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5149539A
(en)
*
|
1990-08-03 |
1992-09-22 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
US5120545A
(en)
*
|
1990-08-03 |
1992-06-09 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
PT99338A
(pt)
*
|
1990-10-29 |
1992-10-30 |
Alza Corp |
Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica
|
US5320850A
(en)
*
|
1990-10-29 |
1994-06-14 |
Alza Corporation |
Transdermal delivery of the gestogen ST-1435 and devices therefor
|
US5314694A
(en)
*
|
1990-10-29 |
1994-05-24 |
Alza Corporation |
Transdermal formulations, methods and devices
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
US5198223A
(en)
*
|
1990-10-29 |
1993-03-30 |
Alza Corporation |
Transdermal formulations, methods and devices
|
DE4115849A1
(de)
*
|
1991-05-15 |
1992-11-19 |
Lohmann Therapie Syst Lts |
Penetrationsfoerdernde substanz
|
US5402777A
(en)
*
|
1991-06-28 |
1995-04-04 |
Alza Corporation |
Methods and devices for facilitated non-invasive oxygen monitoring
|
CN1042699C
(zh)
*
|
1991-07-10 |
1999-03-31 |
生达化学制药股份有限公司 |
雌性激素经皮吸收贴片
|
US5203768A
(en)
*
|
1991-07-24 |
1993-04-20 |
Alza Corporation |
Transdermal delivery device
|
US5464387A
(en)
*
|
1991-07-24 |
1995-11-07 |
Alza Corporation |
Transdermal delivery device
|
US5189986A
(en)
*
|
1991-09-23 |
1993-03-02 |
Alza Corporation |
Veterinary transdermal active agent delivery device
|
US5518734A
(en)
*
|
1991-09-25 |
1996-05-21 |
Beta Pharmaceuticals Co. |
Transdermal delivery system for estradiol and process for manufacturing said device
|
US5705185A
(en)
*
|
1991-09-25 |
1998-01-06 |
Beta Pharmaceuticals Co. |
Transdermal delivery of estradiol and process for manufacturing said device
|
US5352456A
(en)
*
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
PT100973A
(pt)
*
|
1991-10-18 |
1994-06-30 |
Alza Corp |
Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
|
US5229130A
(en)
*
|
1991-12-20 |
1993-07-20 |
Cygnus Therapeutics Systems |
Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
ZA933349B
(en)
*
|
1992-05-13 |
1994-06-15 |
Alza Corp |
Transdermal administration of oxybutynin
|
DE4336557C2
(de)
*
|
1993-05-06 |
1997-07-17 |
Lohmann Therapie Syst Lts |
Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
|
US5330452A
(en)
*
|
1993-06-01 |
1994-07-19 |
Zook Gerald P |
Topical medicating device
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
WO1995001167A2
(fr)
*
|
1993-06-25 |
1995-01-12 |
Alza Corporation |
Incorporation d'un amide poly-n-vinylique a un systeme transdermique
|
US5415866A
(en)
*
|
1993-07-12 |
1995-05-16 |
Zook; Gerald P. |
Topical drug delivery system
|
US5691377A
(en)
*
|
1993-07-30 |
1997-11-25 |
University Of Maryland Eastern Shore And University Of Maryland College Park |
Use of N-methyl-aspartic acid for enhancing growth and altering body composition
|
DE4332094C2
(de)
*
|
1993-09-22 |
1995-09-07 |
Lohmann Therapie Syst Lts |
Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
|
KR960011044B1
(ko)
*
|
1993-09-27 |
1996-08-16 |
재단법인 한국화학연구소 |
알칸올 투과가 우수한 고분자막
|
EP0721348B1
(fr)
*
|
1993-09-29 |
1999-09-01 |
Alza Corporation |
Renforcateur de permeation a base de monoglyceride/lactate
|
US5641507A
(en)
*
|
1993-12-06 |
1997-06-24 |
Devillez; Richard L. |
Delivery system for dermatological and cosmetic ingredients
|
US5962011A
(en)
*
|
1993-12-06 |
1999-10-05 |
Schering-Plough Healthcare Products, Inc. |
Device for delivery of dermatological ingredients
|
US5466465A
(en)
*
|
1993-12-30 |
1995-11-14 |
Harrogate Holdings, Limited |
Transdermal drug delivery system
|
DE4400770C1
(de)
*
|
1994-01-13 |
1995-02-02 |
Lohmann Therapie Syst Lts |
Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
|
US5635203A
(en)
*
|
1994-09-29 |
1997-06-03 |
Alza Corporation |
Transdermal device having decreased delamination
|
US5505958A
(en)
*
|
1994-10-31 |
1996-04-09 |
Algos Pharmaceutical Corporation |
Transdermal drug delivery device and method for its manufacture
|
WO1996019205A1
(fr)
*
|
1994-12-21 |
1996-06-27 |
Theratech, Inc. |
Systeme de liberation transdermique avec opercule adhesif et rondelle pelable
|
DE19500662C2
(de)
*
|
1995-01-12 |
2001-04-26 |
Lohmann Therapie Syst Lts |
Estradiolhaltiges Pflaster und seine Verwendung
|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5840327A
(en)
*
|
1995-08-21 |
1998-11-24 |
Alza Corporation |
Transdermal drug delivery device having enhanced adhesion
|
US5902603A
(en)
*
|
1995-09-14 |
1999-05-11 |
Cygnus, Inc. |
Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
|
US5891461A
(en)
*
|
1995-09-14 |
1999-04-06 |
Cygnus, Inc. |
Transdermal administration of olanzapine
|
US6238700B1
(en)
|
1995-12-01 |
2001-05-29 |
Alza Corporation |
Method for preventing crystal formation in a dispersion of a liquid in a matrix
|
ES2162124T3
(es)
|
1995-12-01 |
2001-12-16 |
Alza Corp |
Metodo mejorado para evitar la formacion de cristales en una dispersion de un liquido en una matriz.
|
US5733571A
(en)
*
|
1995-12-08 |
1998-03-31 |
Euro-Celtique, S.A. |
Transdermal patch for comparative evaluations
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
US6007837A
(en)
*
|
1996-07-03 |
1999-12-28 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
AU4990797A
(en)
*
|
1996-10-24 |
1998-05-15 |
Alza Corporation |
Permeation enhancers for transdermal drug delivery compositions, devices, and methods
|
US6019988A
(en)
*
|
1996-11-18 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
|
DE19701949A1
(de)
*
|
1997-01-13 |
1998-07-16 |
Jenapharm Gmbh |
Transdermales therapeutisches System
|
DE19700913C2
(de)
*
|
1997-01-14 |
2001-01-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Abgabe von Hormonen
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
US5968547A
(en)
*
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
GB9711032D0
(en)
*
|
1997-05-30 |
1997-07-23 |
Johnson Matthey Plc |
Compound as a stimulant for the central nervous system
|
US6174545B1
(en)
|
1997-07-01 |
2001-01-16 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6420622B1
(en)
*
|
1997-08-01 |
2002-07-16 |
3M Innovative Properties Company |
Medical article having fluid control film
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
US6918901B1
(en)
*
|
1997-12-10 |
2005-07-19 |
Felix Theeuwes |
Device and method for enhancing transdermal agent flux
|
EP1037687B8
(fr)
|
1997-12-11 |
2008-10-22 |
Alza Corporation |
Dispositif renfor ant le flux d'agents transdermiques
|
ATE221400T1
(de)
*
|
1997-12-11 |
2002-08-15 |
Alza Corp |
Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
|
DK1037686T3
(da)
*
|
1997-12-11 |
2006-01-02 |
Alza Corp |
Apparat til forögelse af transdermal gennemströmning af midler
|
EP1911488A3
(fr)
|
1997-12-11 |
2008-12-03 |
Alza Corporation |
Dispositif pour améliorer le flux d'agent transdermique
|
AU1623099A
(en)
|
1997-12-22 |
1999-07-12 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
AU1728099A
(en)
|
1997-12-22 |
1999-07-12 |
Alza Corporation |
Monoglyceride and ethyl palmitate permeation enhancer compositions
|
US6269820B1
(en)
|
1998-02-26 |
2001-08-07 |
Xomed Surgical Products, Inc. |
Method of controlling post-operative leakage associated with tumescent liposuction
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
DE19834007C1
(de)
|
1998-07-29 |
2000-02-24 |
Lohmann Therapie Syst Lts |
Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
NZ512432A
(en)
|
1998-12-18 |
2003-10-31 |
Alza Corp |
Transparent transdermal nicotine delivery devices
|
US20070196490A1
(en)
*
|
1999-01-22 |
2007-08-23 |
Powderject Research Limited |
Method of enhancing needleless transdermal powered drug delivery
|
ES2295021T3
(es)
*
|
1999-03-25 |
2008-04-16 |
Metabolix, Inc. |
Utilizacion y aplicaciones medicas de polimeros de poli(hidroxialcanoatos).
|
DE60022174T2
(de)
*
|
1999-04-01 |
2006-02-16 |
Alza Corp., Mountain View |
Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir
|
US6544541B1
(en)
|
1999-06-02 |
2003-04-08 |
Cardiovascular Solutions, Inc. |
Devices and compounds for treating arterial restenosis
|
US6592892B1
(en)
|
1999-08-30 |
2003-07-15 |
Tepha, Inc. |
Flushable disposable polymeric products
|
ES2253278T3
(es)
|
1999-12-10 |
2006-06-01 |
Alza Corporation |
Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
|
JP4653893B2
(ja)
*
|
2000-01-27 |
2011-03-16 |
純一 須藤 |
二層型経皮吸収製剤
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
FR2814074B1
(fr)
*
|
2000-09-15 |
2003-03-07 |
Theramex |
Nouvelles compositions estro-progestatives topiques a effet systemique
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
ES2312585T3
(es)
*
|
2001-06-05 |
2009-03-01 |
Ronald Aung-Din |
Terapia contra la migraña por via topica.
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
US20090162342A1
(en)
*
|
2001-06-07 |
2009-06-25 |
Sanomune Inc. |
Therapeutic uses of glandular kallikrein
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
EA007240B1
(ru)
*
|
2002-06-10 |
2006-08-25 |
Еуро-Селтик С. А. |
Системы дезактивации активного вещества в трансдермальном средстве
|
US7099713B2
(en)
|
2002-06-28 |
2006-08-29 |
Battelle Memorial Institute |
Skin conduction and transport systems
|
US8450302B2
(en)
*
|
2002-08-02 |
2013-05-28 |
Ab Science |
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
|
BRPI0313165B8
(pt)
|
2002-08-02 |
2021-05-25 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazóis e sua utilização como inibidores de c-kit
|
US20040126323A1
(en)
*
|
2002-08-20 |
2004-07-01 |
Ihor Shevchuk |
Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent
|
US7192614B2
(en)
|
2002-11-05 |
2007-03-20 |
Gelstat Corporation |
Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US20040086579A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Higgins James W. |
Dietary supplement comprising parthenolide
|
US7060303B2
(en)
*
|
2002-12-31 |
2006-06-13 |
Avon Products, Inc. |
Use of purslane to treat facial wrinkles
|
US6866856B2
(en)
*
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
US20040191301A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Van Duren Albert Philip |
Transdermal device having a phase change material
|
EP1608347B1
(fr)
*
|
2003-03-28 |
2014-08-13 |
Sigmoid Pharma Limited |
Forme posologique solide s'administrant par voie orale qui contient des microcapsules sans soudure
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
CA2525132C
(fr)
|
2003-05-08 |
2011-06-28 |
Tepha, Inc. |
Textiles et fibres de polyhydroxyalkanoate utilises en medecine
|
US20040247705A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
|
US20040247706A1
(en)
*
|
2003-06-06 |
2004-12-09 |
Roberts Stephen C. |
Transdermal dietary supplement comprising parthenolide
|
US20060200100A1
(en)
*
|
2003-06-18 |
2006-09-07 |
Rosati Coni F |
Method and apparatus for supplying gas to an area
|
EP1644004A4
(fr)
*
|
2003-06-20 |
2010-10-06 |
Ronald Aung-Din |
Therapie locale pour le traitement des migraines, des claquages musculaires, des spasmes musculaires, de la spasticite et d'etats apparentes
|
US20050025809A1
(en)
*
|
2003-07-08 |
2005-02-03 |
Tepha, Inc. |
Poly-4-hydroxybutyrate matrices for sustained drug delivery
|
JP2007500711A
(ja)
|
2003-07-28 |
2007-01-18 |
アルザ・コーポレーシヨン |
経皮的ワーファリン−含有送達システム
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
JP2007503221A
(ja)
*
|
2003-08-22 |
2007-02-22 |
テファ, インコーポレイテッド |
ポリヒドロキシアルカノエート神経再生デバイス
|
CN1950347B
(zh)
*
|
2003-10-23 |
2012-04-04 |
Ab科学公司 |
作为酪氨酸激酶抑制剂的2-氨基芳基噁唑化合物
|
EP1682211B1
(fr)
|
2003-10-27 |
2009-11-18 |
Universität Basel |
Systeme d'administration transdermique de medicament
|
US7504385B2
(en)
*
|
2003-12-17 |
2009-03-17 |
Avon Products, Inc. |
si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US20050232983A1
(en)
*
|
2004-04-14 |
2005-10-20 |
Indevus Pharmaceuticals, Inc. |
Transdermal patch
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
PT1778305E
(pt)
*
|
2004-08-03 |
2010-07-27 |
Tepha Inc |
Suturas de poli-hidroxialcanoato que no se enrolam
|
US7780981B2
(en)
*
|
2004-09-13 |
2010-08-24 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
US20080113031A1
(en)
*
|
2004-09-27 |
2008-05-15 |
Joey Moodley |
Minicapsule Formulations
|
US20060127463A1
(en)
*
|
2004-12-15 |
2006-06-15 |
Nugara Peter N |
Composite structure including a low vinyl acetate layer
|
WO2006066117A1
(fr)
*
|
2004-12-17 |
2006-06-22 |
Alza Corporation |
Modulation de la temperature d'administration transdermique de medicaments
|
US7410658B2
(en)
*
|
2004-12-22 |
2008-08-12 |
Avon Products, Inc. |
Use of Alisma orientale in cosmetics and compositions thereof
|
US7514092B2
(en)
|
2004-12-22 |
2009-04-07 |
Avon Products, Inc. |
Compositions and methods of their use for improving the condition and appearance of skin
|
US7618662B2
(en)
|
2004-12-22 |
2009-11-17 |
Avon Products, Inc |
Use of natural plant extracts in cosmetic compositions
|
US7351745B2
(en)
|
2004-12-22 |
2008-04-01 |
Avon Products, Inc |
Compositions and methods of their use for improving the condition and appearance of skin
|
DE102004062614B4
(de)
*
|
2004-12-24 |
2011-12-29 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
|
US20060177513A1
(en)
*
|
2005-01-28 |
2006-08-10 |
Tepha, Inc. |
Embolization using poly-4-hydroxybutyrate particles
|
US20060188558A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Mylan Technologies, Inc. |
Transdermal systems having control delivery system
|
MX2007012392A
(es)
*
|
2005-04-04 |
2007-12-05 |
Ab Science |
Derivados de oxazol sustituidos y su uso como inhibidores de tirosina cinasa.
|
EP1895995A2
(fr)
|
2005-05-13 |
2008-03-12 |
Alza Corporation |
Systeme d'administration de galantamine a couches multiples equipe d'une protection contre l ecoulement un flux de matiere de reservoir
|
WO2006127905A2
(fr)
|
2005-05-24 |
2006-11-30 |
Chrono Therapeutics, Inc. |
Dispositif d'apport de medicament portatif comprenant un element de dosage et d'administration detachable et remplaçable
|
US8383149B2
(en)
*
|
2005-09-23 |
2013-02-26 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
WO2007035942A2
(fr)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Systeme d'administration de risperidone par voie transdermique
|
US20070104771A1
(en)
*
|
2005-09-23 |
2007-05-10 |
Jay Audett |
Transdermal galantamine delivery system
|
WO2007035940A2
(fr)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Systeme d'administration de norelgestromine par voie transdermique
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
DK2026803T3
(da)
|
2006-05-16 |
2012-04-16 |
Knopp Neurosciences Inc |
Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
US7833284B2
(en)
*
|
2006-06-28 |
2010-11-16 |
The Cleveland Clinic Foundation |
Anti-adhesion membrane
|
CN101516396B
(zh)
|
2006-09-26 |
2013-10-09 |
传染性疾病研究院 |
包含合成佐剂的疫苗组合物
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
US7642062B2
(en)
*
|
2006-12-29 |
2010-01-05 |
Avon Products Inc. |
Compositions and methods of their use for improving the condition and appearance of skin
|
US20100143270A1
(en)
*
|
2007-02-21 |
2010-06-10 |
University Of Louisville Research Foubdation |
Therapeutic cotinine compositions
|
AU2008224844B2
(en)
|
2007-03-14 |
2012-08-09 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
US8940326B2
(en)
|
2007-03-19 |
2015-01-27 |
Vita Sciences Llc |
Transdermal patch and method for delivery of vitamin B12
|
CN103120653B
(zh)
|
2007-04-04 |
2015-09-30 |
希格默伊德药业有限公司 |
一种口服药物组合物
|
JP2010527285A
(ja)
*
|
2007-04-26 |
2010-08-12 |
シグモイド・ファーマ・リミテッド |
複数のミニカプセルの製造
|
US20100239665A1
(en)
*
|
2007-05-01 |
2010-09-23 |
Ivan Coulter |
Pharmaceutical nimodipine compositions
|
WO2009003466A1
(fr)
*
|
2007-07-04 |
2009-01-08 |
Acino Ag |
Système à réservoir muni d'une membrane fermée
|
US20090304776A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Totada Shantha |
Transmucosal delivery of therapeutic agents and methods of use thereof
|
US7883487B2
(en)
*
|
2008-06-16 |
2011-02-08 |
Shantha Totada R |
Transdermal local anesthetic patch with injection port
|
WO2010005507A1
(fr)
|
2008-06-30 |
2010-01-14 |
Afgin Pharma, Llc |
Traitement neuro-affectif régional topique
|
CN102186350A
(zh)
|
2008-08-19 |
2011-09-14 |
诺普神经科学股份有限公司 |
使用(r)-普拉克索的组合物与方法
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
US20100209484A1
(en)
*
|
2009-02-13 |
2010-08-19 |
Hoo-Kyun Choi |
Transdermal Triptan Delivery System
|
EP3300723A1
(fr)
|
2009-05-18 |
2018-04-04 |
Sigmoid Pharma Limited |
Composition comprenant des gouttes d'huile
|
US8722064B2
(en)
|
2009-06-05 |
2014-05-13 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
US20110009460A1
(en)
*
|
2009-06-19 |
2011-01-13 |
Valentin Gribkoff |
Compositions and methods for treating amyotrophic lateral sclerosis
|
JP5911799B2
(ja)
|
2009-08-12 |
2016-04-27 |
シグモイド・ファーマ・リミテッドSigmoid Pharma Limited |
ポリマーマトリックスおよび油相を含んで成る免疫調節組成物
|
KR101750125B1
(ko)
|
2010-01-12 |
2017-06-22 |
에이비 사이언스 |
티아졸 및 옥사졸 키나제 저해제
|
US20120302577A1
(en)
|
2010-01-28 |
2012-11-29 |
Ab Science |
Treatment of gist with masitinib
|
WO2011135533A2
(fr)
|
2010-04-28 |
2011-11-03 |
Kimberly-Clark Worldwide, Inc. |
Dispositif médical à nanomotifs présentant une meilleure interaction cellulaire
|
WO2011135531A2
(fr)
|
2010-04-28 |
2011-11-03 |
Kimberly-Clark Worldwide, Inc. |
DISPOSITIFS MÉDICAUX POUR L'ADMINISTRATION D'ARNsi
|
EP2563455A4
(fr)
|
2010-04-28 |
2014-02-19 |
Kimberly Clark Co |
Procédé d'augmentation de la perméabilité d'une barrière épithéliale
|
WO2011135530A2
(fr)
|
2010-04-28 |
2011-11-03 |
Kimberly-Clark Worldwide, Inc. |
Dispositif pour administrer un médicament contre l'arthrite rhumatoïde
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
AU2012205791B2
(en)
|
2011-01-10 |
2016-11-03 |
Invion, Ltd. |
Use of beta-adrenergic inverse agonists for smoking cessation
|
US8696637B2
(en)
|
2011-02-28 |
2014-04-15 |
Kimberly-Clark Worldwide |
Transdermal patch containing microneedles
|
EP2681208B1
(fr)
|
2011-03-03 |
2016-05-18 |
Denovamed Inc. |
Composés antimicrobiens/d'adjuvants
|
EP3632463A1
(fr)
|
2011-04-08 |
2020-04-08 |
Immune Design Corp. |
Compositions immunogènes et leurs procédés d'utilisation pour induire des réponses immunitaires humorales et cellulaires
|
EP2729148A4
(fr)
|
2011-07-06 |
2015-04-22 |
Parkinson S Inst |
Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson
|
MX2014001079A
(es)
|
2011-07-27 |
2014-09-12 |
Ab Science |
Derivados de oxazoly tiazol como inhibidores de la proteina quinasa selectiva (c-kit).
|
JP6100271B2
(ja)
|
2011-10-27 |
2017-03-22 |
キンバリー クラーク ワールドワイド インコーポレイテッド |
高粘性生理活性薬剤の経皮的送達
|
US9512096B2
(en)
|
2011-12-22 |
2016-12-06 |
Knopp Biosciences, LLP |
Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
PL2811981T3
(pl)
|
2012-02-07 |
2019-09-30 |
Infectious Disease Research Institute |
Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
|
NZ701881A
(en)
|
2012-05-16 |
2016-10-28 |
Immune Design Corp |
Vaccines for hsv-2
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
ES2625548T3
(es)
|
2012-06-04 |
2017-07-19 |
DiaMedica Therapeutics Inc. |
Isoformas de glicosilación de la calicreína-1 tisular humana
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
JP6542128B2
(ja)
|
2013-01-11 |
2019-07-10 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニルのプロドラッグ
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
US10258682B2
(en)
|
2013-01-16 |
2019-04-16 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Attenuated chlamydia vaccine
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
AU2014251207B2
(en)
|
2013-04-07 |
2019-06-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
EP3711768A1
(fr)
|
2013-04-18 |
2020-09-23 |
Immune Design Corp. |
Monothérapie de gla destinée à être utilisée dans le traitement du cancer
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
ES2858500T3
(es)
|
2013-07-12 |
2021-09-30 |
Knopp Biosciences Llc |
Tratamiento de niveles elevados de eosinófilos y/o basófilos
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
HUE055850T2
(hu)
|
2013-08-13 |
2022-01-28 |
Knopp Biosciences Llc |
Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére
|
AU2014306683B2
(en)
|
2013-08-13 |
2017-10-12 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
JP2016537360A
(ja)
|
2013-11-22 |
2016-12-01 |
ジェンザイム・コーポレーション |
神経変性疾患を治療するための新規な方法
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
CN106456724A
(zh)
|
2013-12-20 |
2017-02-22 |
博德研究所 |
使用新抗原疫苗的联合疗法
|
CN105960241A
(zh)
|
2014-01-21 |
2016-09-21 |
免疫设计公司 |
用于治疗过敏性病症的组合物
|
CA2942078C
(fr)
|
2014-03-14 |
2023-03-14 |
The University Of North Carolina At Chapel Hill |
Petites molecules pour inhiber la fertilite male
|
SG11201607525UA
(en)
|
2014-03-24 |
2016-10-28 |
Ab Science |
Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
|
EP3169660A1
(fr)
|
2014-07-16 |
2017-05-24 |
Corsair Pharma, Inc. |
Composés de dérivés de tréprostinil et leurs procédés d'utilisation
|
WO2016025329A1
(fr)
|
2014-08-15 |
2016-02-18 |
Tepha, Inc. |
Sutures auto-rétentive de poly-4-hydroxybutyrate et de copolymères de celui-ci
|
EP3215127B1
(fr)
|
2014-11-07 |
2020-10-28 |
Sublimity Therapeutics Limited |
Compositions comprenant de la cyclosporine
|
WO2016094669A1
(fr)
|
2014-12-11 |
2016-06-16 |
Tepha, Inc. |
Procédés d'orientation de fil multifilament et de monofilaments de poly-4-hydroxybutyrate et de copolymères de celui-ci
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
EP3234193B1
(fr)
|
2014-12-19 |
2020-07-15 |
Massachusetts Institute of Technology |
Biomarqueurs moléculaires pour l'immunothérapie d'un cancer
|
EP3234130B1
(fr)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Procédé pour profiler le répertoire de récepteurs de cellulles t.
|
CA2974324A1
(fr)
|
2015-01-28 |
2016-08-04 |
Zita S. Netzel |
Procedes et systemes d'administration de medicament
|
EP3053920B1
(fr)
|
2015-02-05 |
2020-04-08 |
AB Science |
Composés présentant une activité antitumorale
|
BR112017018944A2
(pt)
|
2015-03-02 |
2018-05-15 |
Afgin Pharma Llc |
método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
JP2018511127A
(ja)
|
2015-03-12 |
2018-04-19 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
渇望入力及び支援システム
|
TWI806815B
(zh)
|
2015-05-20 |
2023-07-01 |
美商博德研究所有限公司 |
共有之gata3相關之腫瘤特異性新抗原
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
EP3144307A1
(fr)
|
2015-09-18 |
2017-03-22 |
AB Science |
Nouveaux derivés d'oxazoles comme inhibiteurs de syk kinase
|
WO2017184590A1
(fr)
|
2016-04-18 |
2017-10-26 |
The Broad Institute Inc. |
Prédiction améliorée d'épitope hla
|
MX2018013640A
(es)
|
2016-05-16 |
2019-08-01 |
Infectious Disease Res Inst |
Liposomas pegiladas y metodos de uso.
|
EP3458475B1
(fr)
|
2016-05-16 |
2022-07-27 |
Access to Advanced Health Institute |
Formulation contenant un agoniste de tlr et procédés d'utilisation
|
IL298227B1
(en)
|
2016-06-01 |
2024-05-01 |
Access To Advanced Health Inst |
Nanoalum particles containing a fixing factor
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
JP2020500882A
(ja)
|
2016-12-05 |
2020-01-16 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニルおよびその塩の皮膚投与および経皮投与方法
|
WO2018129304A1
(fr)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Dispositifs et methodes d'administration transdermique de medicament
|
US11549149B2
(en)
|
2017-01-24 |
2023-01-10 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
JP2020510023A
(ja)
|
2017-03-09 |
2020-04-02 |
ダイアメディカ, インコーポレイテッド |
組織カリクレイン1の剤形
|
WO2018231706A1
(fr)
|
2017-06-11 |
2018-12-20 |
Molecular Express, Inc. |
Méthodes et compositions destinées à des formulations vaccinales contre des troubles liés à une substance, et leurs utilisations
|
WO2019169479A1
(fr)
|
2018-03-05 |
2019-09-12 |
Denovamed Inc. |
Dérivés de thiophène-2-amide à substitution diphényle et compositions pharmaceutiques de ceux-ci utiles en tant qu'agent antimicrobien
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
US20220062394A1
(en)
|
2018-12-17 |
2022-03-03 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
MX2023007648A
(es)
|
2020-12-23 |
2023-08-29 |
Access To Advanced Health Inst |
Adyuvantes de vacuna de solanesol y métodos para prepararlos.
|
NL2035417A
(en)
|
2022-07-19 |
2024-01-26 |
Coty Inc |
Cosmetic composition
|